| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.79 | 0.004 | 0.816 | Anticonvulsant | 0.774 0.004 DBMET01408 0.663 0.005 DBMET01409 0.509 0.012 DBMET01413 0.774 0.004 DBMET02148 0.774 0.004 DBMET01410 0.816 0.004 DBMET01411 0.509 0.012 DBMET01412 | DBMET01411 | |
| 0.65 | 0.041 | 0.679 | Antiinflammatory | 0.66 0.039 DBMET01408 0.427 0.123 DBMET01409 0.289 0.225 DBMET01413 0.66 0.039 DBMET02148 0.66 0.039 DBMET01410 0.679 0.035 DBMET01411 0.289 0.225 DBMET01412 | DBMET01411 | |
| 0.523 | 0.024 | 0.523 | 5 Hydroxytryptamine release stimulant | 0.403 0.045 DBMET01408 0.444 0.037 DBMET01409 0.403 0.045 DBMET02148 0.403 0.045 DBMET01410 | ||
| 0.497 | 0.05 | 0.604 | Analgesic | 0.604 0.026 DBMET01408 0.452 0.065 DBMET01409 0.244 0.188 DBMET01413 0.604 0.026 DBMET02148 0.604 0.026 DBMET01410 0.244 0.188 DBMET01412 | DBMET01410 | |
| 0.395 | 0.017 | 0.485 | Anesthetic general | 0.485 0.009 DBMET01408 0.396 0.017 DBMET01409 0.189 0.08 DBMET01413 0.485 0.009 DBMET02148 0.485 0.009 DBMET01410 0.189 0.08 DBMET01412 | DBMET01410 | |
| 0.367 | 0.019 | 0.367 | P-glycoprotein inhibitor | 0.184 0.076 DBMET01408 0.174 0.085 DBMET01409 0.145 0.125 DBMET01413 0.184 0.076 DBMET02148 0.184 0.076 DBMET01410 0.145 0.125 DBMET01412 | ||
| 0.344 | 0.066 | 0.437 | Immunostimulant | 0.328 0.071 DBMET01408 0.244 0.098 DBMET01409 0.421 0.044 DBMET01413 0.328 0.071 DBMET02148 0.328 0.071 DBMET01410 0.437 0.04 DBMET01411 0.421 0.044 DBMET01412 | DBMET01411 | |
| 0.292 | 0.018 | 0.292 | Protein kinase stimulant | 0.189 0.046 DBMET01408 0.189 0.046 DBMET02148 0.189 0.046 DBMET01410 | ||
| 0.329 | 0.065 | 0.329 | Calcium channel activator | 0.28 0.113 DBMET01408 0.259 0.137 DBMET01409 0.28 0.113 DBMET02148 0.28 0.113 DBMET01410 | ||
| 0.293 | 0.034 | 0.293 | Growth hormone agonist | 0.169 0.074 DBMET01408 0.125 0.113 DBMET01409 0.284 0.035 DBMET01413 0.169 0.074 DBMET02148 0.169 0.074 DBMET01410 0.284 0.035 DBMET01412 | ||
| 0.269 | 0.015 | 0.409 | Interleukin 1 antagonist | 0.256 0.018 DBMET01408 0.409 0.005 DBMET01409 0.22 0.026 DBMET01413 0.256 0.018 DBMET02148 0.256 0.018 DBMET01410 0.22 0.026 DBMET01412 | DBMET01409 | |
| 0.376 | 0.123 | 0.457 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.417 0.086 DBMET01408 0.457 0.057 DBMET01409 0.417 0.086 DBMET02148 0.417 0.086 DBMET01410 | DBMET01409 | |
| 0.294 | 0.046 | 0.323 | DNA synthesis inhibitor | 0.291 0.047 DBMET01408 0.292 0.046 DBMET01409 0.323 0.037 DBMET01413 0.291 0.047 DBMET02148 0.291 0.047 DBMET01410 0.178 0.157 DBMET01411 0.323 0.037 DBMET01412 | DBMET01412 | |
| 0.289 | 0.054 | 0.289 | Interleukin agonist | 0.241 0.086 DBMET01408 0.241 0.086 DBMET02148 0.241 0.086 DBMET01410 | ||
| 0.27 | 0.036 | 0.35 | Non-steroidal antiinflammatory agent | 0.198 0.073 DBMET01408 0.35 0.019 DBMET01409 0.217 0.059 DBMET01413 0.198 0.073 DBMET02148 0.198 0.073 DBMET01410 0.217 0.059 DBMET01412 | DBMET01409 | |
| 0.315 | 0.082 | 0.506 | Cholesterol antagonist | 0.299 0.092 DBMET01408 0.188 0.176 DBMET01409 0.299 0.092 DBMET02148 0.299 0.092 DBMET01410 0.506 0.032 DBMET01411 | DBMET01411 | |
| 0.29 | 0.074 | 0.29 | Spasmolytic | 0.273 0.081 DBMET01408 0.178 0.139 DBMET01409 0.16 0.155 DBMET01413 0.273 0.081 DBMET02148 0.273 0.081 DBMET01410 0.176 0.14 DBMET01411 0.16 0.155 DBMET01412 | ||
| 0.258 | 0.057 | 0.258 | Antimitotic | |||
| 0.28 | 0.089 | 0.345 | Interleukin 2 agonist | 0.345 0.048 DBMET01408 0.297 0.076 DBMET01413 0.345 0.048 DBMET02148 0.345 0.048 DBMET01410 0.197 0.194 DBMET01411 0.297 0.076 DBMET01412 | DBMET01410 | |
| 0.258 | 0.07 | 0.258 | Gastrin inhibitor | 0.207 0.138 DBMET01408 0.253 0.076 DBMET01409 0.243 0.087 DBMET01413 0.207 0.138 DBMET02148 0.207 0.138 DBMET01410 0.243 0.087 DBMET01412 | ||
| 0.287 | 0.1 | 0.661 | Angiogenesis inhibitor | 0.295 0.095 DBMET01408 0.321 0.083 DBMET01409 0.295 0.095 DBMET02148 0.295 0.095 DBMET01410 0.661 0.011 DBMET01411 | DBMET01411 | |
| 0.227 | 0.042 | 0.227 | Lipocortins synthesis antagonist | 0.176 0.074 DBMET01408 0.176 0.074 DBMET02148 0.176 0.074 DBMET01410 | ||
| 0.258 | 0.077 | 0.292 | Cardiotonic | 0.292 0.06 DBMET01408 0.292 0.06 DBMET02148 0.292 0.06 DBMET01410 | DBMET01410 | |
| 0.194 | 0.028 | 0.194 | Alkylator | 0.164 0.04 DBMET01408 0.118 0.07 DBMET01409 0.169 0.038 DBMET01413 0.164 0.04 DBMET02148 0.164 0.04 DBMET01410 0.11 0.078 DBMET01411 0.169 0.038 DBMET01412 | ||
| 0.233 | 0.08 | 0.233 | Vasodilator | |||
| 0.213 | 0.065 | 0.213 | Neurotrophic factor enhancer | 0.192 0.084 DBMET01408 0.163 0.119 DBMET01409 0.192 0.084 DBMET02148 0.192 0.084 DBMET01410 | ||
| 0.165 | 0.018 | 0.165 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 DBMET01408 0.136 0.089 DBMET01409 0.152 0.038 DBMET02148 0.152 0.038 DBMET01410 | ||
| 0.153 | 0.009 | 0.677 | NMDA 2B receptor antagonist | 0.3 0.004 DBMET01408 0.098 0.016 DBMET01409 0.3 0.004 DBMET02148 0.3 0.004 DBMET01410 0.677 0.003 DBMET01411 | DBMET01411 | |
| 0.174 | 0.031 | 0.174 | Adenylate cyclase stimulant | 0.164 0.043 DBMET01408 0.139 0.083 DBMET01409 0.164 0.043 DBMET02148 0.164 0.043 DBMET01410 0.165 0.041 DBMET01411 | ||
| 0.217 | 0.077 | 0.348 | RNA-directed DNA polymerase inhibitor | 0.21 0.085 DBMET01408 0.207 0.09 DBMET01409 0.21 0.085 DBMET02148 0.21 0.085 DBMET01410 0.348 0.024 DBMET01411 | DBMET01411 | |
| 0.171 | 0.033 | 0.171 | Cyclooxygenase 3 inhibitor | 0.11 0.09 DBMET01408 0.11 0.09 DBMET02148 0.11 0.09 DBMET01410 | ||
| 0.314 | 0.179 | 0.318 | Caspase 9 stimulant | 0.263 0.238 DBMET01408 0.318 0.175 DBMET01409 0.263 0.238 DBMET02148 0.263 0.238 DBMET01410 | DBMET01409 | |
| 0.21 | 0.075 | 0.21 | Psychostimulant | 0.151 0.115 DBMET01408 0.195 0.082 DBMET01413 0.151 0.115 DBMET02148 0.151 0.115 DBMET01410 0.195 0.082 DBMET01412 | ||
| 0.141 | 0.008 | 0.141 | Glycine receptor agonist | 0.125 0.011 DBMET01408 0.066 0.062 DBMET01409 0.125 0.011 DBMET02148 0.125 0.011 DBMET01410 0.066 0.063 DBMET01411 | ||
| 0.232 | 0.101 | 0.315 | 5 Hydroxytryptamine uptake stimulant | 0.256 0.075 DBMET01408 0.315 0.038 DBMET01409 0.232 0.1 DBMET01413 0.256 0.075 DBMET02148 0.256 0.075 DBMET01410 0.232 0.1 DBMET01412 | DBMET01409 | |
| 0.226 | 0.096 | 0.295 | Tyrosine 3 hydroxylase inhibitor | 0.255 0.063 DBMET01408 0.295 0.036 DBMET01409 0.219 0.105 DBMET01413 0.255 0.063 DBMET02148 0.255 0.063 DBMET01410 0.219 0.105 DBMET01412 | DBMET01409 | |
| 0.253 | 0.125 | 0.253 | Transcription factor NF kappa B inhibitor | |||
| 0.256 | 0.129 | 0.256 | Vasodilator, coronary | |||
| 0.249 | 0.128 | 0.249 | Vasodilator, peripheral | 0.219 0.155 DBMET01408 0.219 0.155 DBMET02148 0.219 0.155 DBMET01410 | ||
| 0.264 | 0.143 | 0.451 | GABA C receptor rho-3 antagonist | 0.319 0.104 DBMET01408 0.451 0.041 DBMET01409 0.319 0.104 DBMET02148 0.319 0.104 DBMET01410 | DBMET01409 | |
| 0.183 | 0.075 | 0.183 | Nitric oxide antagonist | 0.134 0.112 DBMET01408 0.134 0.112 DBMET02148 0.134 0.112 DBMET01410 | ||
| 0.185 | 0.087 | 0.185 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.174 0.102 DBMET01408 0.174 0.102 DBMET02148 0.174 0.102 DBMET01410 | ||
| 0.261 | 0.167 | 0.3 | Antibacterial | 0.225 0.201 DBMET01408 0.225 0.201 DBMET02148 0.225 0.201 DBMET01410 0.3 0.135 DBMET01411 | DBMET01411 | |
| 0.131 | 0.037 | 0.142 | UDP-glucose 4-epimerase inhibitor | 0.142 0.032 DBMET01408 0.098 0.063 DBMET01409 0.142 0.032 DBMET02148 0.142 0.032 DBMET01410 | DBMET01410 | |
| 0.177 | 0.083 | 0.199 | Hepatoprotectant | 0.191 0.071 DBMET01408 0.132 0.131 DBMET01413 0.191 0.071 DBMET02148 0.191 0.071 DBMET01410 0.199 0.065 DBMET01411 0.132 0.131 DBMET01412 | DBMET01411 | |
| 0.149 | 0.057 | 0.209 | Nav1.2 sodium channel blocker | 0.155 0.054 DBMET01408 0.19 0.038 DBMET01409 0.155 0.054 DBMET02148 0.155 0.054 DBMET01410 0.209 0.031 DBMET01411 | DBMET01411 | |
| 0.126 | 0.034 | 0.143 | Anabolic | 0.115 0.044 DBMET01408 0.106 0.055 DBMET01409 0.115 0.044 DBMET02148 0.115 0.044 DBMET01410 0.143 0.022 DBMET01411 | DBMET01411 | |
| 0.275 | 0.185 | 0.363 | Cyclophilin D inhibitor | 0.363 0.113 DBMET01408 0.363 0.113 DBMET02148 0.363 0.113 DBMET01410 | DBMET01410 | |
| 0.183 | 0.095 | 0.206 | Platelet aggregation inhibitor | 0.155 0.123 DBMET01408 0.206 0.077 DBMET01409 0.16 0.116 DBMET01413 0.155 0.123 DBMET02148 0.155 0.123 DBMET01410 0.16 0.116 DBMET01412 | DBMET01409 | |
| 0.182 | 0.095 | 0.323 | Interleukin antagonist | 0.233 0.068 DBMET01408 0.305 0.047 DBMET01409 0.323 0.043 DBMET01413 0.233 0.068 DBMET02148 0.233 0.068 DBMET01410 0.323 0.043 DBMET01412 | DBMET01412 | |
| 0.231 | 0.146 | 0.31 | Apoptosis antagonist | 0.222 0.155 DBMET01408 0.31 0.079 DBMET01413 0.222 0.155 DBMET02148 0.222 0.155 DBMET01410 0.31 0.079 DBMET01412 | DBMET01412 | |
| 0.106 | 0.021 | 0.106 | Calcium channel L-type blocker | |||
| 0.095 | 0.016 | 0.095 | Androgen agonist | 0.086 0.021 DBMET01408 0.086 0.021 DBMET02148 0.086 0.021 DBMET01410 0.093 0.018 DBMET01411 | ||
| 0.126 | 0.054 | 0.126 | Microtubule formation inhibitor | |||
| 0.089 | 0.021 | 0.15 | Alcohol oxidase inhibitor | 0.15 0.01 DBMET01408 0.084 0.023 DBMET01409 0.15 0.01 DBMET02148 0.15 0.01 DBMET01410 | DBMET01410 | |
| 0.268 | 0.204 | 0.314 | 5 Hydroxytryptamine release inhibitor | 0.314 0.149 DBMET01409 | DBMET01409 | |
| 0.129 | 0.069 | 0.263 | Alpha-N-acetylglucosaminidase inhibitor | 0.222 0.028 DBMET01408 0.263 0.021 DBMET01413 0.222 0.028 DBMET02148 0.222 0.028 DBMET01410 0.263 0.021 DBMET01412 | DBMET01412 | |
| 0.199 | 0.141 | 0.261 | Lipoxygenase inhibitor | 0.236 0.11 DBMET01408 0.261 0.093 DBMET01409 0.236 0.11 DBMET02148 0.236 0.11 DBMET01410 | DBMET01409 | |
| 0.072 | 0.015 | 0.078 | Ryanodine receptor antagonist | 0.076 0.011 DBMET01408 0.078 0.01 DBMET01409 0.076 0.011 DBMET02148 0.076 0.011 DBMET01410 | DBMET01409 | |
| 0.067 | 0.014 | 0.067 | Adenylate cyclase 1 inhibitor | 0.055 0.022 DBMET01408 0.055 0.022 DBMET02148 0.055 0.022 DBMET01410 | ||
| 0.107 | 0.057 | 0.157 | Adenylate kinase inhibitor | 0.157 0.024 DBMET01408 0.107 0.057 DBMET01409 0.137 0.032 DBMET01413 0.157 0.024 DBMET02148 0.157 0.024 DBMET01410 0.093 0.08 DBMET01411 0.137 0.032 DBMET01412 | DBMET01410 | |
| 0.097 | 0.049 | 0.097 | Antineoplastic alkaloid | |||
| 0.101 | 0.053 | 0.127 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.127 0.035 DBMET01408 0.087 0.069 DBMET01409 0.091 0.065 DBMET01413 0.127 0.035 DBMET02148 0.127 0.035 DBMET01410 0.091 0.065 DBMET01412 | DBMET01410 | |
| 0.143 | 0.096 | 0.148 | Arachidonic acid antagonist | 0.148 0.091 DBMET01408 0.148 0.091 DBMET02148 0.148 0.091 DBMET01410 | DBMET01410 | |
| 0.1 | 0.055 | 0.127 | Prolactin inhibitor | 0.091 0.066 DBMET01408 0.089 0.068 DBMET01409 0.127 0.034 DBMET01413 0.091 0.066 DBMET02148 0.091 0.066 DBMET01410 0.127 0.034 DBMET01412 | DBMET01412 | |
| 0.139 | 0.095 | 0.139 | Interferon gamma antagonist | 0.134 0.103 DBMET01408 0.132 0.106 DBMET01409 0.134 0.103 DBMET02148 0.134 0.103 DBMET01410 | ||
| 0.087 | 0.046 | 0.181 | Glycine receptor antagonist | 0.118 0.019 DBMET01408 0.074 0.066 DBMET01409 0.118 0.019 DBMET02148 0.118 0.019 DBMET01410 0.181 0.004 DBMET01411 | DBMET01411 | |
| 0.124 | 0.083 | 0.124 | Calcium channel blocker | |||
| 0.11 | 0.071 | 0.122 | Photosensitizer | 0.122 0.055 DBMET01409 | DBMET01409 | |
| 0.252 | 0.212 | 0.252 | Apoptosis agonist | |||
| 0.109 | 0.072 | 0.109 | TRPA1 agonist | 0.104 0.081 DBMET01409 | ||
| 0.056 | 0.02 | 0.056 | Microtubule stabilization | |||
| 0.112 | 0.076 | 0.112 | Acetylcholine muscarinic antagonist | |||
| 0.068 | 0.036 | 0.068 | Nitric oxide donor | |||
| 0.114 | 0.083 | 0.148 | Cathepsin H inhibitor | 0.104 0.1 DBMET01408 0.123 0.071 DBMET01409 0.148 0.048 DBMET01413 0.104 0.1 DBMET02148 0.104 0.1 DBMET01410 0.148 0.048 DBMET01412 | DBMET01412 | |
| 0.085 | 0.055 | 0.093 | Inducible nitric-oxide synthase inhibitor | 0.093 0.044 DBMET01408 0.076 0.07 DBMET01409 0.093 0.044 DBMET02148 0.093 0.044 DBMET01410 0.077 0.067 DBMET01411 | DBMET01410 | |
| 0.07 | 0.044 | 0.113 | Acetylcholine M5 receptor agonist | 0.113 0.014 DBMET01409 | DBMET01409 | |
| 0.07 | 0.047 | 0.07 | Elastase 1 inhibitor | 0.067 0.051 DBMET01413 0.067 0.051 DBMET01412 | ||
| 0.097 | 0.075 | 0.097 | Toll-Like receptor 4 antagonist | |||
| 0.065 | 0.043 | 0.066 | Interferon inducer | 0.061 0.052 DBMET01408 0.061 0.052 DBMET02148 0.061 0.052 DBMET01410 0.066 0.041 DBMET01411 | DBMET01411 | |
| 0.094 | 0.073 | 0.116 | Glutamate (mGluR7) agonist | 0.114 0.037 DBMET01408 0.112 0.04 DBMET01409 0.116 0.034 DBMET01413 0.114 0.037 DBMET02148 0.114 0.037 DBMET01410 0.116 0.034 DBMET01412 | DBMET01412 | |
| 0.039 | 0.018 | 0.078 | Vasopressin 2 antagonist | 0.078 0.008 DBMET01408 0.078 0.008 DBMET02148 0.078 0.008 DBMET01410 | DBMET01410 | |
| 0.077 | 0.057 | 0.077 | Interferon agonist | 0.071 0.068 DBMET01408 0.071 0.068 DBMET02148 0.071 0.068 DBMET01410 0.076 0.059 DBMET01411 | ||
| 0.168 | 0.148 | 0.182 | DNA damaging | 0.182 0.132 DBMET01409 | DBMET01409 | |
| 0.061 | 0.042 | 0.113 | Carbamoyl phosphate synthetase inhibitor | 0.113 0.017 DBMET01408 0.062 0.041 DBMET01409 0.08 0.029 DBMET01413 0.113 0.017 DBMET02148 0.113 0.017 DBMET01410 0.055 0.049 DBMET01411 0.08 0.029 DBMET01412 | DBMET01410 | |
| 0.105 | 0.089 | 0.105 | Cholinergic antagonist | |||
| 0.084 | 0.068 | 0.178 | Triose-phosphate isomerase inhibitor | 0.11 0.039 DBMET01408 0.087 0.064 DBMET01409 0.096 0.052 DBMET01413 0.11 0.039 DBMET02148 0.11 0.039 DBMET01410 0.178 0.014 DBMET01411 0.096 0.052 DBMET01412 | DBMET01411 | |
| 0.208 | 0.193 | 0.4 | Histamine release inhibitor | 0.216 0.185 DBMET01408 0.4 0.076 DBMET01409 0.216 0.185 DBMET02148 0.216 0.185 DBMET01410 | DBMET01409 | |
| 0.02 | 0.009 | 0.031 | Complement factor D inhibitor | 0.023 0.005 DBMET01408 0.031 0.004 DBMET01409 0.023 0.005 DBMET02148 0.023 0.005 DBMET01410 | DBMET01409 | |
| 0.052 | 0.045 | 0.126 | Argininosuccinate synthase inhibitor | 0.089 0.022 DBMET01408 0.063 0.035 DBMET01409 0.126 0.014 DBMET01413 0.089 0.022 DBMET02148 0.089 0.022 DBMET01410 0.126 0.014 DBMET01412 | DBMET01412 | |
| 0.095 | 0.089 | 0.095 | Adenylate cyclase inhibitor | |||
| 0.093 | 0.087 | 0.093 | Mucolytic | |||
| 0.053 | 0.048 | 0.053 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.056 | 0.051 | 0.117 | Purinergic P2X1 antagonist | 0.117 0.012 DBMET01408 0.081 0.024 DBMET01409 0.117 0.012 DBMET02148 0.117 0.012 DBMET01410 0.057 0.048 DBMET01411 | DBMET01410 | |
| 0.109 | 0.105 | 0.205 | Lipid peroxidase inhibitor | 0.111 0.104 DBMET01408 0.205 0.04 DBMET01409 0.111 0.104 DBMET02148 0.111 0.104 DBMET01410 | DBMET01409 | |
| 0.149 | 0.146 | 0.231 | Platelet antagonist | 0.231 0.081 DBMET01413 0.231 0.081 DBMET01412 | DBMET01412 | |
| 0.086 | 0.085 | 0.135 | GABA C receptor rho-1 antagonist | 0.11 0.05 DBMET01408 0.135 0.029 DBMET01409 0.11 0.05 DBMET02148 0.11 0.05 DBMET01410 | DBMET01409 | |
| 0.067 | 0.067 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.049 DBMET01408 0.074 0.049 DBMET01409 0.075 0.049 DBMET02148 0.075 0.049 DBMET01410 | DBMET01410 | |
| 0.026 | 0.027 | 0.042 | Acetylcholine M4 receptor agonist | 0.042 0.014 DBMET01408 0.042 0.014 DBMET02148 0.042 0.014 DBMET01410 | DBMET01410 | |
| 0.082 | 0.084 | 0.17 | Creatine kinase inhibitor | 0.16 0.02 DBMET01408 0.17 0.017 DBMET01409 0.16 0.02 DBMET02148 0.16 0.02 DBMET01410 | DBMET01409 | |
| 0.061 | 0.063 | 0.074 | Glutamate (mGluR6) antagonist | 0.074 0.032 DBMET01408 0.064 0.054 DBMET01409 0.066 0.048 DBMET01413 0.074 0.032 DBMET02148 0.074 0.032 DBMET01410 0.066 0.048 DBMET01412 | DBMET01410 | |
| 0.063 | 0.067 | 0.079 | Na+ K+ transporting ATPase inhibitor | 0.073 0.057 DBMET01408 0.073 0.057 DBMET02148 0.073 0.057 DBMET01410 0.079 0.051 DBMET01411 | DBMET01411 | |
| 0.045 | 0.049 | 0.061 | Aconitate hydratase inhibitor | 0.061 0.025 DBMET01408 0.061 0.025 DBMET01409 0.048 0.042 DBMET01413 0.061 0.025 DBMET02148 0.061 0.025 DBMET01410 0.048 0.042 DBMET01412 | DBMET01410 | |
| 0.135 | 0.141 | 0.183 | Phospholipase C inhibitor | 0.165 0.079 DBMET01408 0.153 0.101 DBMET01409 0.138 0.132 DBMET01413 0.165 0.079 DBMET02148 0.165 0.079 DBMET01410 0.183 0.057 DBMET01411 0.138 0.132 DBMET01412 | DBMET01411 | |
| 0.084 | 0.091 | 0.102 | Ferrochelatase inhibitor | 0.098 0.073 DBMET01408 0.102 0.069 DBMET01409 0.098 0.073 DBMET02148 0.098 0.073 DBMET01410 | DBMET01409 | |
| 0.047 | 0.054 | 0.088 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.088 0.017 DBMET01408 0.088 0.017 DBMET02148 0.088 0.017 DBMET01410 | DBMET01410 | |
| 0.088 | 0.097 | 0.167 | Nav1.4 sodium channel blocker | 0.108 0.064 DBMET01408 0.103 0.072 DBMET01409 0.127 0.047 DBMET01413 0.108 0.064 DBMET02148 0.108 0.064 DBMET01410 0.167 0.027 DBMET01411 0.127 0.047 DBMET01412 | DBMET01411 | |
| 0.163 | 0.173 | 0.17 | Nitric-oxide synthase stimulant | 0.17 0.153 DBMET01408 0.17 0.153 DBMET02148 0.17 0.153 DBMET01410 | DBMET01410 | |
| 0.027 | 0.039 | 0.053 | Antidiuretic hormone antagonist | 0.053 0.022 DBMET01408 0.053 0.022 DBMET02148 0.053 0.022 DBMET01410 | DBMET01410 | |
| 0.029 | 0.041 | 0.037 | Antibiotic Aminoglycoside-like | 0.037 0.024 DBMET01408 0.037 0.024 DBMET02148 0.037 0.024 DBMET01410 | DBMET01410 | |
| 0.093 | 0.105 | 0.163 | Acetylcholine release stimulant | 0.098 0.093 DBMET01409 0.163 0.01 DBMET01411 | DBMET01411 | |
| 0.151 | 0.164 | 0.192 | Antioxidant | 0.17 0.142 DBMET01408 0.17 0.142 DBMET02148 0.17 0.142 DBMET01410 0.192 0.12 DBMET01411 | DBMET01411 | |
| 0.081 | 0.094 | 0.092 | Nitric-oxide synthase inhibitor | 0.092 0.075 DBMET01408 0.092 0.075 DBMET02148 0.092 0.075 DBMET01410 | DBMET01410 | |
| 0.043 | 0.06 | 0.098 | HIV-1 integrase (Strand Transfer) inhibitor | 0.098 0.023 DBMET01411 | DBMET01411 | |
| 0.057 | 0.074 | 0.061 | Calcium channel P-type blocker | 0.06 0.056 DBMET01408 0.061 0.054 DBMET01409 0.06 0.056 DBMET02148 0.06 0.056 DBMET01410 | DBMET01409 | |
| 0.057 | 0.074 | 0.09 | Glutamate (mGluR7) antagonist | 0.068 0.045 DBMET01408 0.09 0.017 DBMET01409 0.068 0.045 DBMET02148 0.068 0.045 DBMET01410 | DBMET01409 | |
| 0.132 | 0.15 | 0.171 | Succinate dehydrogenase inhibitor | 0.149 0.115 DBMET01408 0.162 0.092 DBMET01409 0.171 0.079 DBMET01413 0.149 0.115 DBMET02148 0.149 0.115 DBMET01410 0.171 0.079 DBMET01412 | DBMET01412 | |
| 0.079 | 0.097 | 0.175 | GABA C receptor agonist | 0.156 0.032 DBMET01408 0.155 0.032 DBMET01409 0.175 0.026 DBMET01413 0.156 0.032 DBMET02148 0.156 0.032 DBMET01410 0.175 0.026 DBMET01412 | DBMET01412 | |
| 0.045 | 0.063 | 0.085 | Biliverdin reductase inhibitor | 0.085 0.024 DBMET01408 0.085 0.024 DBMET02148 0.085 0.024 DBMET01410 | DBMET01410 | |
| 0.057 | 0.075 | 0.084 | Protein kinase C beta inhibitor | 0.084 0.025 DBMET01408 0.076 0.036 DBMET01409 0.084 0.025 DBMET02148 0.084 0.025 DBMET01410 | DBMET01410 | |
| 0.098 | 0.117 | 0.162 | NADPH oxidase inhibitor | 0.162 0.048 DBMET01408 0.159 0.049 DBMET01409 0.162 0.048 DBMET02148 0.162 0.048 DBMET01410 | DBMET01410 | |
| 0.074 | 0.093 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.1 0.035 DBMET01409 | DBMET01409 | |
| 0.056 | 0.077 | 0.143 | Glutamate decarboxylase inhibitor | 0.069 0.056 DBMET01408 0.129 0.018 DBMET01409 0.143 0.014 DBMET01413 0.069 0.056 DBMET02148 0.069 0.056 DBMET01410 0.143 0.014 DBMET01412 | DBMET01412 | |
| 0.121 | 0.142 | 0.136 | CF transmembrane conductance regulator agonist | 0.136 0.104 DBMET01409 | DBMET01409 | |
| 0.058 | 0.08 | 0.091 | Glutamate dehydrogenase inhibitor | 0.09 0.036 DBMET01408 0.091 0.036 DBMET01413 0.09 0.036 DBMET02148 0.09 0.036 DBMET01410 0.091 0.036 DBMET01412 | DBMET01412 | |
| 0.181 | 0.203 | 0.349 | Antithrombotic | 0.325 0.074 DBMET01413 0.349 0.065 DBMET01411 0.325 0.074 DBMET01412 | DBMET01411 | |
| 0.072 | 0.095 | 0.118 | NADH dehydrogenase inhibitor | 0.118 0.03 DBMET01408 0.083 0.068 DBMET01409 0.118 0.03 DBMET02148 0.118 0.03 DBMET01410 | DBMET01410 | |
| 0.12 | 0.144 | 0.234 | Platelet adhesion inhibitor | 0.234 0.055 DBMET01411 | DBMET01411 | |
| 0.047 | 0.073 | 0.106 | Phosphofructokinase-1 inhibitor | 0.101 0.031 DBMET01408 0.106 0.029 DBMET01413 0.101 0.031 DBMET02148 0.101 0.031 DBMET01410 0.106 0.029 DBMET01412 | DBMET01412 | |
| 0.039 | 0.066 | 0.085 | 5 Hydroxytryptamine 3 antagonist | 0.075 0.026 DBMET01408 0.085 0.022 DBMET01409 0.075 0.026 DBMET02148 0.075 0.026 DBMET01410 | DBMET01409 | |
| 0.014 | 0.043 | 0.027 | RNA-directed RNA polymerase stimulant | 0.027 0.023 DBMET01408 0.027 0.023 DBMET02148 0.027 0.023 DBMET01410 | DBMET01410 | |
| 0.021 | 0.05 | 0.034 | Fumarate hydratase inhibitor | 0.034 0.024 DBMET01408 0.034 0.024 DBMET02148 0.034 0.024 DBMET01410 | DBMET01410 | |
| 0.033 | 0.065 | 0.043 | Farnesyltransferase inhibitor | 0.043 0.036 DBMET01409 | DBMET01409 | |
| 0.049 | 0.081 | 0.105 | Histidine decarboxylase inhibitor | 0.105 0.03 DBMET01408 0.077 0.044 DBMET01409 0.105 0.03 DBMET02148 0.105 0.03 DBMET01410 | DBMET01410 | |
| 0.049 | 0.081 | 0.179 | Catalase inhibitor | 0.179 0.019 DBMET01413 0.067 0.058 DBMET01411 0.179 0.019 DBMET01412 | DBMET01412 | |
| 0.032 | 0.064 | 0.042 | Kainate receptor agonist | 0.042 0.026 DBMET01408 0.042 0.026 DBMET02148 0.042 0.026 DBMET01410 | DBMET01410 | |
| 0.052 | 0.087 | 0.07 | Aminopeptidase I inhibitor | 0.07 0.053 DBMET01408 0.07 0.053 DBMET02148 0.07 0.053 DBMET01410 | DBMET01410 | |
| 0.151 | 0.186 | 0.329 | Superoxide dismutase inhibitor | 0.225 0.093 DBMET01408 0.234 0.086 DBMET01409 0.192 0.126 DBMET01413 0.225 0.093 DBMET02148 0.225 0.093 DBMET01410 0.329 0.042 DBMET01411 0.192 0.126 DBMET01412 | DBMET01411 | |
| 0.096 | 0.133 | 0.238 | Peroxidase inhibitor | 0.216 0.055 DBMET01408 0.238 0.05 DBMET01409 0.216 0.055 DBMET02148 0.216 0.055 DBMET01410 | DBMET01409 | |
| 0.08 | 0.117 | 0.127 | GABA C receptor antagonist | 0.118 0.055 DBMET01408 0.127 0.046 DBMET01409 0.118 0.055 DBMET02148 0.118 0.055 DBMET01410 0.096 0.084 DBMET01411 | DBMET01409 | |
| 0.042 | 0.079 | 0.062 | Angiotensin-converting enzyme inhibitor | 0.062 0.027 DBMET01413 0.062 0.027 DBMET01412 | DBMET01412 | |
| 0.02 | 0.057 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 DBMET01411 | DBMET01411 | |
| 0.076 | 0.113 | 0.122 | Cystathionine beta-synthase inhibitor | 0.122 0.056 DBMET01408 0.119 0.059 DBMET01409 0.122 0.056 DBMET02148 0.122 0.056 DBMET01410 | DBMET01410 | |
| 0.048 | 0.085 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.051 DBMET01409 0.059 0.054 DBMET01413 0.059 0.054 DBMET01412 | DBMET01409 | |
| 0.11 | 0.149 | 0.17 | GABA C receptor rho-2 antagonist | 0.124 0.118 DBMET01408 0.17 0.051 DBMET01409 0.124 0.118 DBMET02148 0.124 0.118 DBMET01410 | DBMET01409 | |
| 0.019 | 0.058 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.03 0.024 DBMET01409 | DBMET01409 | |
| 0.066 | 0.106 | 0.191 | Butyrylcholinesterase inhibitor | 0.098 0.064 DBMET01408 0.191 0.023 DBMET01409 0.098 0.064 DBMET02148 0.098 0.064 DBMET01410 | DBMET01409 | |
| 0.034 | 0.074 | 0.057 | Acyl-CoA dehydrogenase inhibitor | 0.057 0.035 DBMET01408 0.057 0.035 DBMET02148 0.057 0.035 DBMET01410 | DBMET01410 | |
| 0.024 | 0.064 | 0.043 | Vascular adhesion protein 1 inhibitor | 0.038 0.028 DBMET01408 0.043 0.021 DBMET01409 0.038 0.028 DBMET02148 0.038 0.028 DBMET01410 | DBMET01409 | |
| 0.088 | 0.131 | 0.161 | Sodium channel (voltage-gated) blocker | 0.161 0.047 DBMET01409 | DBMET01409 | |
| 0.097 | 0.143 | 0.183 | Cell wall synthesis inhibitor | 0.183 0.038 DBMET01411 | DBMET01411 | |
| 0.021 | 0.07 | 0.044 | Toll-Like receptor 2 agonist | 0.044 0.026 DBMET01413 0.044 0.026 DBMET01412 | DBMET01412 | |
| 0.041 | 0.091 | 0.09 | HIV-1 integrase (3'-Processing) inhibitor | 0.09 0.03 DBMET01411 | DBMET01411 | |
| 0.051 | 0.102 | 0.096 | Phospholipase D inhibitor | 0.08 0.034 DBMET01408 0.076 0.04 DBMET01409 0.08 0.034 DBMET02148 0.08 0.034 DBMET01410 0.096 0.017 DBMET01411 | DBMET01411 | |
| 0.032 | 0.087 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.032 DBMET01408 0.048 0.032 DBMET02148 0.048 0.032 DBMET01410 | DBMET01410 | |
| 0.074 | 0.129 | 0.114 | Cholesterol synthesis inhibitor | 0.114 0.071 DBMET01411 | DBMET01411 | |
| 0.081 | 0.139 | 0.114 | Aldehyde dehydrogenase inhibitor | 0.114 0.077 DBMET01409 | DBMET01409 | |
| 0.025 | 0.083 | 0.052 | Ornithine carbamoyltransferase inhibitor | 0.046 0.044 DBMET01408 0.052 0.038 DBMET01413 0.046 0.044 DBMET02148 0.046 0.044 DBMET01410 0.052 0.038 DBMET01412 | DBMET01412 | |
| 0.108 | 0.166 | 0.134 | Sphingosine 1-phosphate receptor 5 antagonist | 0.134 0.092 DBMET01409 | DBMET01409 | |
| 0.027 | 0.09 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.034 DBMET01408 0.035 0.034 DBMET02148 0.035 0.034 DBMET01410 | DBMET01410 | |
| 0.169 | 0.235 | 0.215 | MAP kinase kinase 3 inhibitor | 0.192 0.146 DBMET01408 0.215 0.084 DBMET01409 0.192 0.146 DBMET02148 0.192 0.146 DBMET01410 | DBMET01409 | |
| 0.024 | 0.091 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.025 DBMET01413 0.036 0.025 DBMET01412 | DBMET01412 | |
| 0.143 | 0.213 | 0.219 | Peptidyltransferase inhibitor | 0.219 0.078 DBMET01408 0.172 0.142 DBMET01413 0.219 0.078 DBMET02148 0.219 0.078 DBMET01410 0.172 0.142 DBMET01412 | DBMET01410 | |
| 0.025 | 0.094 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.03 DBMET01413 0.036 0.03 DBMET01412 | DBMET01412 | |
| 0.021 | 0.091 | 0.054 | Phosphorylase inhibitor | 0.054 0.028 DBMET01408 0.054 0.028 DBMET02148 0.054 0.028 DBMET01410 | DBMET01410 | |
| 0.045 | 0.115 | 0.082 | Analgesic, opioid | 0.077 0.052 DBMET01408 0.082 0.045 DBMET01413 0.077 0.052 DBMET02148 0.077 0.052 DBMET01410 0.082 0.045 DBMET01412 | DBMET01412 | |
| 0.067 | 0.139 | 0.085 | Xanthine oxidase inhibitor | 0.085 0.081 DBMET01409 | DBMET01409 | |
| 0.053 | 0.128 | 0.176 | Aminopeptidase B inhibitor | 0.176 0.028 DBMET01413 0.128 0.048 DBMET01411 0.176 0.028 DBMET01412 | DBMET01412 | |
| 0.065 | 0.141 | 0.146 | GABA receptor agonist | 0.146 0.038 DBMET01409 | DBMET01409 | |
| 0.126 | 0.203 | 0.2 | Cyclic AMP phosphodiesterase inhibitor | 0.2 0.094 DBMET01409 | DBMET01409 | |
| 0.038 | 0.116 | 0.087 | Porphobilinogen synthase inhibitor | 0.087 0.043 DBMET01409 | DBMET01409 | |
| 0.068 | 0.147 | 0.105 | Protein kinase C gamma inhibitor | 0.105 0.069 DBMET01408 0.096 0.085 DBMET01409 0.105 0.069 DBMET02148 0.105 0.069 DBMET01410 | DBMET01410 | |
| 0.076 | 0.158 | 0.161 | Sodium channel blocker | 0.161 0.05 DBMET01409 | DBMET01409 | |
| 0.087 | 0.172 | 0.233 | Diuretic | 0.233 0.034 DBMET01411 | DBMET01411 | |
| 0.018 | 0.103 | 0.026 | Hedgehog signaling activator | 0.026 0.025 DBMET01408 0.026 0.025 DBMET02148 0.026 0.025 DBMET01410 | DBMET01410 | |
| 0.035 | 0.121 | 0.065 | Phenylalanine 4-hydroxylase inhibitor | 0.065 0.052 DBMET01408 0.065 0.052 DBMET02148 0.065 0.052 DBMET01410 | DBMET01410 | |
| 0.039 | 0.128 | 0.087 | Cathepsin G inhibitor | 0.087 0.039 DBMET01413 0.087 0.039 DBMET01412 | DBMET01412 | |
| 0.075 | 0.166 | 0.186 | Thrombolytic | 0.186 0.059 DBMET01413 0.181 0.062 DBMET01411 0.186 0.059 DBMET01412 | DBMET01412 | |
| 0.014 | 0.107 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET01408 0.03 0.017 DBMET02148 0.03 0.017 DBMET01410 | DBMET01410 | |
| 0.145 | 0.244 | 0.223 | 5 Hydroxytryptamine 3E antagonist | 0.223 0.034 DBMET01409 | DBMET01409 | |
| 0.048 | 0.148 | 0.059 | Prolactin release inhibitor | 0.059 0.056 DBMET01408 0.059 0.056 DBMET02148 0.059 0.056 DBMET01410 | DBMET01410 | |
| 0.013 | 0.114 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.014 DBMET01411 | DBMET01411 | |
| 0.05 | 0.159 | 0.098 | HIV-1 integrase (Overall Integration) inhibitor | 0.087 0.069 DBMET01408 0.098 0.057 DBMET01409 0.087 0.069 DBMET02148 0.087 0.069 DBMET01410 | DBMET01409 | |
| 0.089 | 0.197 | 0.138 | NOS3 expression enhancer | 0.138 0.086 DBMET01408 0.119 0.118 DBMET01413 0.138 0.086 DBMET02148 0.138 0.086 DBMET01410 0.119 0.118 DBMET01412 | DBMET01410 | |
| 0.011 | 0.12 | 0.04 | Kinesin-like protein 1 inhibitor | 0.04 0.022 DBMET01409 | DBMET01409 | |
| 0.011 | 0.12 | 0.04 | Kinesin antagonist | 0.04 0.022 DBMET01409 | DBMET01409 | |
| 0.097 | 0.209 | 0.135 | Interleukin 6 antagonist | 0.135 0.115 DBMET01408 0.135 0.115 DBMET02148 0.135 0.115 DBMET01410 | DBMET01410 | |
| 0.14 | 0.255 | 0.191 | Immunomodulator | 0.191 0.174 DBMET01408 0.191 0.174 DBMET02148 0.191 0.174 DBMET01410 | DBMET01410 | |
| 0.077 | 0.194 | 0.541 | Anticoagulant | 0.309 0.027 DBMET01413 0.541 0.008 DBMET01411 0.309 0.027 DBMET01412 | DBMET01411 | |
| 0.068 | 0.185 | 0.125 | Cyclooxygenase inhibitor | 0.125 0.092 DBMET01409 | DBMET01409 | |
| 0.073 | 0.19 | 0.245 | Factor V inhibitor | 0.245 0.003 DBMET01413 0.245 0.003 DBMET01412 | DBMET01412 | |
| 0.096 | 0.217 | 0.218 | Aldehyde oxidase inhibitor | 0.218 0.096 DBMET01408 0.191 0.109 DBMET01409 0.218 0.096 DBMET02148 0.218 0.096 DBMET01410 | DBMET01410 | |
| 0.056 | 0.181 | 0.102 | DNA polymerase I inhibitor | 0.102 0.084 DBMET01408 0.102 0.084 DBMET02148 0.102 0.084 DBMET01410 | DBMET01410 | |
| 0.088 | 0.215 | 0.282 | Hemostatic | 0.282 0.018 DBMET01411 | DBMET01411 | |
| 0.045 | 0.176 | 0.116 | Protease inhibitor | 0.116 0.051 DBMET01413 0.116 0.051 DBMET01412 | DBMET01412 | |
| 0.085 | 0.217 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.11 DBMET01409 | DBMET01409 | |
| 0.013 | 0.153 | 0.052 | Carbonic anhydrase VB inhibitor | 0.052 0.043 DBMET01411 | DBMET01411 | |
| 0.062 | 0.204 | 0.105 | DOPA decarboxylase inhibitor | 0.105 0.066 DBMET01409 | DBMET01409 | |
| 0.036 | 0.18 | 0.08 | GABA aminotransferase inhibitor | 0.08 0.047 DBMET01413 0.08 0.047 DBMET01412 | DBMET01412 | |
| 0.176 | 0.321 | 0.41 | Calcium channel L-type activator | 0.41 0.074 DBMET01409 | DBMET01409 | |
| 0.033 | 0.183 | 0.155 | NMDA receptor antagonist | 0.078 0.068 DBMET01408 0.109 0.041 DBMET01409 0.078 0.068 DBMET02148 0.078 0.068 DBMET01410 0.155 0.023 DBMET01411 | DBMET01411 | |
| 0.013 | 0.165 | 0.07 | NMDA 2A receptor antagonist | 0.07 0.024 DBMET01409 | DBMET01409 | |
| 0.02 | 0.172 | 0.053 | GABA receptor antagonist | 0.053 0.04 DBMET01409 | DBMET01409 | |
| 0.053 | 0.207 | 0.13 | MAP kinase kinase 1 inhibitor | 0.13 0.027 DBMET01408 0.1 0.057 DBMET01409 0.13 0.027 DBMET02148 0.13 0.027 DBMET01410 | DBMET01410 | |
| 0.021 | 0.178 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.039 DBMET01411 | DBMET01411 | |
| 0.016 | 0.176 | 0.31 | NMDA 2 receptor antagonist | 0.1 0.032 DBMET01408 0.1 0.032 DBMET02148 0.1 0.032 DBMET01410 0.31 0.005 DBMET01411 | DBMET01411 | |
| 0.036 | 0.197 | 0.151 | Caspase 9 inhibitor | 0.151 0.005 DBMET01413 0.151 0.005 DBMET01412 | DBMET01412 | |
| 0.04 | 0.201 | 0.091 | Platelet activating factor antagonist | 0.091 0.087 DBMET01409 | DBMET01409 | |
| 0.02 | 0.187 | 0.048 | GABA A receptor antagonist | 0.048 0.043 DBMET01409 | DBMET01409 | |
| 0.009 | 0.177 | 0.046 | Caspase 2 inhibitor | 0.046 0.013 DBMET01413 0.046 0.013 DBMET01412 | DBMET01412 | |
| 0.022 | 0.19 | 0.091 | Aminopeptidase microsomal inhibitor | 0.091 0.02 DBMET01409 | DBMET01409 | |
| 0.014 | 0.185 | 0.041 | Mannosidase inhibitor | 0.041 0.038 DBMET01411 | DBMET01411 | |
| 0.026 | 0.199 | 0.093 | Platelet activating factor beta antagonist | 0.093 0.068 DBMET01409 | DBMET01409 | |
| 0.023 | 0.198 | 0.069 | Cyclin D1 inhibitor | 0.069 0.03 DBMET01409 | DBMET01409 | |
| 0.021 | 0.203 | 0.05 | Purinergic P2X4 antagonist | 0.05 0.025 DBMET01409 | DBMET01409 | |
| 0.019 | 0.202 | 0.067 | Carbonic anhydrase V inhibitor | 0.067 0.046 DBMET01411 | DBMET01411 | |
| 0.024 | 0.212 | 0.06 | Heparanase inhibitor | 0.06 0.024 DBMET01411 | DBMET01411 | |
| 0.07 | 0.263 | 0.14 | Cyclin-dependent kinase 8 inhibitor | 0.14 0.089 DBMET01408 0.14 0.089 DBMET02148 0.14 0.089 DBMET01410 | DBMET01410 | |
| 0.015 | 0.212 | 0.497 | Cholecystokinin B agonist | 0.497 0.002 DBMET01411 | DBMET01411 | |
| 0.055 | 0.263 | 0.541 | Angiogenesis stimulant | 0.541 0.01 DBMET01411 | DBMET01411 | |
| 0.013 | 0.223 | 0.068 | Aminopeptidase N inhibitor | 0.068 0.021 DBMET01409 | DBMET01409 | |
| 0.053 | 0.265 | 0.141 | 3C-Like protease (SARS coronavirus) inhibitor | 0.141 0.011 DBMET01413 0.141 0.011 DBMET01412 | DBMET01412 | |
| 0.004 | 0.218 | 0.146 | Cholecystokinin B antagonist | 0.146 0.005 DBMET01411 | DBMET01411 | |
| 0.032 | 0.246 | 0.083 | Adenine nucleotide translocase inhibitor | 0.083 0.008 DBMET01411 | DBMET01411 | |
| 0.043 | 0.262 | 0.079 | MAP kinase kinase 7 inhibitor | 0.079 0.048 DBMET01408 0.079 0.048 DBMET02148 0.079 0.048 DBMET01410 | DBMET01410 | |
| 0.02 | 0.245 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.034 DBMET01411 | DBMET01411 | |
| 0.059 | 0.288 | 0.177 | Heat shock protein 90 antagonist | 0.177 0.05 DBMET01409 | DBMET01409 | |
| 0.037 | 0.269 | 0.144 | 5 Hydroxytryptamine 3A agonist | 0.144 0.039 DBMET01409 | DBMET01409 | |
| 0.004 | 0.243 | 0.217 | Cholecystokinin A antagonist | 0.217 0.004 DBMET01411 | DBMET01411 | |
| 0.005 | 0.249 | 0.032 | Trypsin I inhibitor | 0.032 0.024 DBMET01413 0.032 0.024 DBMET01412 | DBMET01412 | |
| 0.005 | 0.249 | 0.163 | Cholecystokinin antagonist | 0.038 0.031 DBMET01413 0.163 0.005 DBMET01411 0.038 0.031 DBMET01412 | DBMET01411 | |
| 0.008 | 0.256 | 0.047 | Opioid mu receptor agonist | 0.047 0.031 DBMET01413 0.047 0.031 DBMET01412 | DBMET01412 | |
| 0.036 | 0.285 | 0.105 | Cell adhesion molecule inhibitor | 0.105 0.031 DBMET01411 | DBMET01411 | |
| 0.079 | 0.329 | 0.248 | 5 Hydroxytryptamine 1E antagonist | 0.248 0.077 DBMET01409 | DBMET01409 | |
| 0.048 | 0.301 | 0.101 | Cell adhesion inhibitor | 0.101 0.088 DBMET01411 | DBMET01411 | |
| 0.013 | 0.27 | 0.043 | Poly(ADP-ribose) polymerase inhibitor | 0.043 0.034 DBMET01409 | DBMET01409 | |
| 0.019 | 0.282 | 0.139 | MAO A inhibitor | 0.139 0.044 DBMET01409 | DBMET01409 | |
| 0.032 | 0.295 | 0.091 | Chymotrypsin inhibitor | 0.091 0.043 DBMET01413 0.091 0.043 DBMET01412 | DBMET01412 | |
| 0.039 | 0.309 | 0.116 | Protein kinase C nu inhibitor | 0.116 0.098 DBMET01408 0.116 0.098 DBMET02148 0.116 0.098 DBMET01410 | DBMET01410 | |
| 0.05 | 0.335 | 0.13 | Histone deacetylase SIRT1 inhibitor | 0.13 0.08 DBMET01413 0.13 0.08 DBMET01412 | DBMET01412 | |
| 0.026 | 0.317 | 0.156 | Protein kinase C zeta inhibitor | 0.156 0.019 DBMET01411 | DBMET01411 | |
| 0.049 | 0.341 | 0.217 | Heat shock protein 90 alpha antagonist | 0.217 0.04 DBMET01409 | DBMET01409 | |
| 0.014 | 0.31 | 0.108 | 5 Hydroxytryptamine 2C antagonist | 0.108 0.041 DBMET01409 | DBMET01409 | |
| 0.098 | 0.396 | 0.205 | Insulysin inhibitor | 0.205 0.15 DBMET01409 0.201 0.155 DBMET01413 0.201 0.155 DBMET01412 | DBMET01409 | |
| 0.03 | 0.329 | 0.164 | 5 Hydroxytryptamine 2B antagonist | 0.164 0.035 DBMET01409 | DBMET01409 | |
| 0.028 | 0.327 | 0.081 | Trypsin inhibitor | 0.081 0.027 DBMET01413 0.081 0.027 DBMET01412 | DBMET01412 | |
| 0.033 | 0.339 | 0.161 | Caspase 3 inhibitor | 0.161 0.021 DBMET01413 0.161 0.021 DBMET01412 | DBMET01412 | |
| 0.02 | 0.34 | 0.063 | Heat shock protein 90 beta antagonist | 0.063 0.036 DBMET01409 | DBMET01409 | |
| 0.011 | 0.336 | 0.261 | Selectin antagonist | 0.261 0.008 DBMET01411 | DBMET01411 | |
| 0.018 | 0.345 | 0.175 | MAO inhibitor | 0.175 0.05 DBMET01409 | DBMET01409 | |
| 0.006 | 0.335 | 0.048 | Factor Xa inhibitor | 0.048 0.03 DBMET01411 | DBMET01411 | |
| 0.017 | 0.346 | 0.108 | 5 Hydroxytryptamine 2 antagonist | 0.108 0.066 DBMET01409 | DBMET01409 | |
| 0.022 | 0.352 | 0.108 | Glutamate receptor antagonist | 0.102 0.094 DBMET01409 0.108 0.088 DBMET01411 | DBMET01411 | |
| 0.081 | 0.418 | 0.15 | Catenin beta inhibitor | 0.15 0.106 DBMET01413 0.15 0.106 DBMET01412 | DBMET01412 | |
| 0.023 | 0.364 | 0.107 | MAP kinase kinase inhibitor | 0.107 0.087 DBMET01408 0.107 0.087 DBMET02148 0.107 0.087 DBMET01410 | DBMET01410 | |
| 0.006 | 0.349 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 DBMET01413 0.018 0.017 DBMET01412 | DBMET01412 | |
| 0.007 | 0.353 | 0.135 | MAO B inhibitor | 0.135 0.043 DBMET01409 | DBMET01409 | |
| 0.017 | 0.378 | 0.093 | Cathepsin B inhibitor | 0.093 0.019 DBMET01413 0.093 0.019 DBMET01412 | DBMET01412 | |
| 0.004 | 0.369 | 0.334 | Cholecystokinin agonist | 0.334 0.003 DBMET01411 | DBMET01411 | |
| 0.052 | 0.428 | 0.144 | 3C-like protease (Human coronavirus) inhibitor | 0.144 0.112 DBMET01409 | DBMET01409 | |
| 0.013 | 0.398 | 0.096 | CDC25A inhibitor | 0.096 0.03 DBMET01411 | DBMET01411 | |
| 0.028 | 0.422 | 0.171 | MAP kinase kinase 2 inhibitor | 0.171 0.103 DBMET01408 0.171 0.103 DBMET02148 0.171 0.103 DBMET01410 | DBMET01410 | |
| 0.02 | 0.414 | 0.079 | Caspase 7 inhibitor | 0.079 0.064 DBMET01409 | DBMET01409 | |
| 0.027 | 0.424 | 0.128 | Bone formation stimulant | 0.128 0.078 DBMET01413 0.128 0.078 DBMET01412 | DBMET01412 | |
| 0.004 | 0.405 | 0.238 | Cholecystokinin A agonist | 0.238 0.002 DBMET01411 | DBMET01411 | |
| 0.007 | 0.425 | 0.033 | Caspase 6 inhibitor | 0.033 0.015 DBMET01413 0.033 0.015 DBMET01412 | DBMET01412 | |
| 0.037 | 0.486 | 0.141 | Thiol protease inhibitor | 0.141 0.079 DBMET01413 0.141 0.079 DBMET01412 | DBMET01412 | |
| 0.002 | 0.454 | 0.012 | 3C-Like protease (MERS coronavirus) inhibitor | 0.012 0.008 DBMET01413 0.012 0.008 DBMET01412 | DBMET01412 | |
| 0.019 | 0.472 | 0.142 | Interleukin 1 beta converting enzyme inhibitor | 0.142 0.021 DBMET01413 0.142 0.021 DBMET01412 | DBMET01412 | |
| 0.007 | 0.476 | 0.072 | Plasmin inhibitor | 0.072 0.024 DBMET01413 0.072 0.024 DBMET01412 | DBMET01412 | |
| 0.013 | 0.491 | 0.092 | Thrombin inhibitor | 0.092 0.03 DBMET01413 0.075 0.048 DBMET01411 0.092 0.03 DBMET01412 | DBMET01412 | |
| 0.016 | 0.507 | 0.105 | Aminoacyl-tRNA synthetase inhibitor | 0.105 0.04 DBMET01413 0.105 0.04 DBMET01412 | DBMET01412 | |
| 0.01 | 0.509 | 0.036 | Purinergic P2Y2 antagonist | 0.036 0.02 DBMET01411 | DBMET01411 | |
| 0.018 | 0.518 | 0.116 | Factor XII inhibitor | 0.116 0.026 DBMET01413 0.116 0.026 DBMET01412 | DBMET01412 | |
| 0.006 | 0.514 | 0.106 | NMDA 2D receptor antagonist | 0.106 0.004 DBMET01411 | DBMET01411 | |
| 0.039 | 0.576 | 0.116 | Folate antagonist | 0.116 0.043 DBMET01413 0.116 0.043 DBMET01412 | DBMET01412 | |
| 0.021 | 0.586 | 0.167 | Calpain inhibitor | 0.167 0.153 DBMET01413 0.167 0.153 DBMET01412 | DBMET01412 | |
| 0.049 | 0.621 | 0.113 | Sphingosine 1-phosphate receptor 2 agonist | 0.113 0.067 DBMET01408 0.113 0.067 DBMET02148 0.113 0.067 DBMET01410 | DBMET01410 | |
| 0.011 | 0.584 | 0.15 | Protein-tyrosine phosphatase inhibitor | 0.15 0.078 DBMET01411 | DBMET01411 | |
| 0.003 | 0.604 | 0.047 | Calpain 1 inhibitor | 0.047 0.005 DBMET01413 0.047 0.005 DBMET01412 | DBMET01412 | |
| 0.007 | 0.631 | 0.065 | Plasminogen activator inhibitor | 0.065 0.036 DBMET01413 0.065 0.036 DBMET01412 | DBMET01412 | |
| 0.012 | 0.736 | 0.131 | Factor IXa inhibitor | 0.131 0.005 DBMET01411 | DBMET01411 | |
| 0.01 | 0.761 | 0.157 | Multidrug resistance-associated protein 1 inhibitor | 0.157 0.022 DBMET01411 | DBMET01411 | |
| 0.01 | 0.77 | 0.22 | Dual specificity phosphatase inhibitor | 0.22 0.046 DBMET01411 | DBMET01411 | |
| 0.008 | 0.789 | 0.218 | Dual specificity phosphatase 3 inhibitor | 0.218 0.052 DBMET01411 | DBMET01411 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |